Medicare Enrolled

Dr. Victoria Andrews, PA-C

Physician Assistant · Flemington, NJ
Low-engagement
2100 WESCOTT DR, Flemington, NJ 08822
9087886461
In practice since 2011 (14 years)
NPI: 1013290543 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Andrews from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Andrews? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Andrews

Dr. Victoria Andrews is a physician assistant in Flemington, NJ, with 14 years of NPI registration.

Between the years covered by Open Payments, Dr. Andrews received a total of $2,422 from 53 pharmaceutical and/or device companies across 141 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in physician assistant. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Andrews is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 14 years in practice $2,422 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$2,422
Total received (2021-2024)
Avg $606/year across 4 years
Top 12% in NJ for physician assistant
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
53
Companies
141
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,422 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,032
2023
$841
2022
$346
2021
$203

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Daiichi Sankyo Inc.
$112
Takeda Pharmaceuticals U.S.A., Inc.
$96
ABBVIE INC.
$78
Lilly USA, LLC
$74
AstraZeneca Pharmaceuticals LP
$60
Eisai Inc.
$53
Genmab U.S., Inc.
$41
BeiGene USA, Inc.
$38
Novartis Pharmaceuticals Corporation
$38
Janssen Biotech, Inc.
$34
Bayer Healthcare Pharmaceuticals Inc.
$32
Incyte Corporation
$31
Tempus AI, Inc
$24
TAIHO ONCOLOGY, INC.
$21
Adaptive Biotechnologies Corporation
$21
Ipsen Biopharmaceuticals, Inc
$19
Abbott Laboratories
$19
Janssen Pharmaceuticals, Inc
$19
Biocon Biologics Inc
$18
SOBI, INC
$18
GlaxoSmithKline, LLC.
$17
Fresenius Kabi USA, LLC
$17
Mirati Therapeutics, Inc.
$17
Aveo Pharmaceuticals, Inc.
$17
Karyopharm Therapeutics Inc.
$17
Cumberland Pharmaceuticals, Inc.
$15
Stemline Therapeutics Inc.
$15
E.R. Squibb & Sons, L.L.C.
$15
JAZZ PHARMACEUTICALS INC.
$15
Astellas Pharma US Inc
$14
PharmaEssentia USA Corporation
$13
Genentech USA, Inc.
$13
Top 3 companies account for 27.8% of 2024 payments
All-time payments by company (2021-2024) ›
Novartis Pharmaceuticals Corporation
$230
Takeda Pharmaceuticals U.S.A., Inc.
$148
Daiichi Sankyo Inc.
$145
ABBVIE INC.
$138
Janssen Biotech, Inc.
$136
Lilly USA, LLC
$133
Eisai Inc.
$102
Incyte Corporation
$94
AstraZeneca Pharmaceuticals LP
$94
Seagen Inc.
$77
Amgen Inc.
$67
TAIHO ONCOLOGY, INC.
$56
BeiGene USA, Inc.
$56
GlaxoSmithKline, LLC.
$47
MorphoSys, US Inc.
$47
EMD Serono, Inc.
$45
Fresenius Kabi USA, LLC
$43
Genmab U.S., Inc.
$41
Acrotech Biopharma Inc.
$39
Janssen Pharmaceuticals, Inc
$34
GENZYME CORPORATION
$33
Ipsen Biopharmaceuticals, Inc
$32
Bayer Healthcare Pharmaceuticals Inc.
$32
Mirati Therapeutics, Inc.
$32
Pharmacyclics LLC, An AbbVie Company
$31
Boehringer Ingelheim Pharmaceuticals, Inc.
$29
Stemline Therapeutics Inc.
$28
Heron Therapeutics, Inc.
$24
Tempus AI, Inc
$24
Dendreon Pharmaceuticals LLC
$23
Adaptive Biotechnologies Corporation
$21
G1 Therapeutics, Inc.
$19
Abbott Laboratories
$19
Bayer HealthCare Pharmaceuticals Inc.
$18
Biocon Biologics Inc
$18
SOBI, INC
$18
Aveo Pharmaceuticals, Inc.
$17
Karyopharm Therapeutics Inc.
$17
Apellis Pharmaceuticals, Inc.
$16
Regeneron Healthcare Solutions, Inc.
$16
Alexion Pharmaceuticals, Inc.
$16
Cumberland Pharmaceuticals, Inc.
$15
E.R. Squibb & Sons, L.L.C.
$15
AVEO Pharmaceuticals, Inc.
$15
JAZZ PHARMACEUTICALS INC.
$15
Blueprint Medicines Corporation
$15
Foundation Medicine, Inc.
$14
Astellas Pharma US Inc
$14
PharmaEssentia USA Corporation
$13
Celgene Corporation
$13
Genentech USA, Inc.
$13
AbbVie Inc.
$13
Octapharma USA, Inc.
$12
Top 3 companies account for 21.6% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALUNBRIG · AYVAKIT · BAVENCIO · BELEODAQ · BESREMI · BRUKINSA · Blincyto · CALQUENCE · COSELA · CYRAMZA · Columvi · DARZALEX · ELAHERE · ENHERTU · EPKINLY · Empaveli · Enhertu · FOTIVDA · FOUNDATIONONE · FRUZAQLA · GILOTRIF · ICLUSIG · IMBRUVICA · INJECTAFER · JAKAFI · JEMPERLI · JEVTANA · KISQALI · KRAZATI · LIBTAYO · LONSURF · LUMAKRAS · LYNPARZA · Lenvima · MEKINIST · MITRACLIP · MONJUVI · NINLARO · Nubeqa · OJJAARA · OPDUALAG · Ogivri · Onivyde · Orserdu · PADCEV · PANZYGA · PEMAZYRE · PIQRAY · PLUVICTO · PROVENGE · RYBREVANT · SANCUSO · SARCLISA · SKYRIZI · SUSTOL · SYNAGIS · Somatuline Depot · Stimufend · Stivarga · TECVAYLI · TEPMETKO · TUKYSA · Tivdak · ULTOMIRIS · VENCLEXTA · VERZENIO · Vanflyta · Vyloy · XARELTO · XPOVIO · XT CDX · ZEPZELCA · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a physician assistant in Flemington?
Compare physician assistants in the Flemington area by procedure volume, costs, and industry payment transparency.
Browse physician assistants nearby

Geographic Context

Physician assistants within 10 mi
707
Per 100K population
546.2
County median income
$139,453
Nearest hospital
HUNTERDON MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Andrews is a physician assistant, with low-engagement industry engagement in the top 12% of NJ peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Andrews receive payments from pharmaceutical companies?
Yes. Dr. Andrews received a total of $2,422 from 53 companies across 141 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Andrews) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →